drugset / Trial / NCT00300391
ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium
Phase 3
Terminated
40 enrolled
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if treating delirious intensive care unit patients with haloperidol improves mortality.
Timeline
- Start
- 2006-03
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Haloperidol | Other / unclassified | 5 mg | Intravenous |